Daniel B Longley, D Paul Harkin, Patrick G Johnston
Cancer Research Centre, Department of Oncology, Queen's University Belfast, University Floor, Belfast City Hospital, 97 Lisburn Road, Belfast BT9 7AB, Northern Ireland.
Nature reviews. Cancer 2003 May5-fluorouracil (5-FU) is widely used in the treatment of cancer. Over the past 20 years, increased understanding of the mechanism of action of 5-FU has led to the development of strategies that increase its anticancer activity. Despite these advances, drug resistance remains a significant limitation to the clinical use of 5-FU. Emerging technologies, such as DNA microarray profiling, have the potential to identify novel genes that are involved in mediating resistance to 5-FU. Such target genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to 5-FU-based chemotherapy.
Daniel B Longley, D Paul Harkin, Patrick G Johnston. 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews. Cancer. 2003 May;3(5):330-8
PMID: 12724731
View Full Text